Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Jarrod Longcor, MA, MBA, Cellectar Biosciences, Madison, WI, gives his ESMO 2019 highlights, specifically mentioning tyrosine kinase inhibitors and how their use is evolving, immunotherapies and where there are current gabs in research. This interview took place at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.
We use necessary cookies to make this site work. Analytics, preference, and marketing cookies are used only if you choose to allow them. You can change your choice at any time. For more information view our Cookie Policy.